However, the number of genes co-expressed with DAT in PD patients’ samples was too low for further analysis (only six genes), so we selected all DAT co-expressed genes for the analysis, applying the milder cut-off level ρ > 0.5, p < 0.05. This evidence concerns the gene SLC6A3 and Parkinson disease.